BRG On-Demand Webinar
What is the financial impact of the Inflation Reduction Act’s (IRA) drug-pricing provisions on manufacturers?
The IRA includes provisions that could have a significant financial impact on manufacturers. During this hour-long webinar, BRG experts discuss each provision in detail, with a focus on the $22 billion increase in manufacturer discounts that will result from the Part D redesign.
Our experts review:
- how the provisions could impact your company’s bottom line
- how the additional manufacturer discounts are spread unevenly across therapeutic areas and manufacturers
- data-modeling insights and analysis on the financial impact of the IRA